GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Mediq N.V. (XAMS:MEDIQ) » Definitions » Research & Development

Mediq N.V. (XAMS:MEDIQ) Research & Development : €0 Mil (TTM As of Jun. 2012)


View and export this data going back to . Start your Free Trial

What is Mediq N.V. Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Mediq N.V.'s Research & Development for the three months ended in Jun. 2012 was €0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Jun. 2012 was €0 Mil.


Mediq N.V. Research & Development Historical Data

The historical data trend for Mediq N.V.'s Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mediq N.V. Research & Development Chart

Mediq N.V. Annual Data
Trend Dec04 Dec05 Dec06 Dec07 Dec08 Dec09 Dec10 Dec11
Research & Development
Get a 7-Day Free Trial - - - - -

Mediq N.V. Quarterly Data
Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

Mediq N.V. Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Jun. 2012 adds up the quarterly data reported by the company within the most recent 12 months, which was €0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Mediq N.V.  (XAMS:MEDIQ) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.


Mediq N.V. Research & Development Related Terms

Thank you for viewing the detailed overview of Mediq N.V.'s Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.


Mediq N.V. (XAMS:MEDIQ) Business Description

Traded in Other Exchanges
N/A
Address
Website

Mediq N.V. (XAMS:MEDIQ) Headlines

No Headlines